United States · Platforms & data · MarketBeat

ADARx Pharmaceuticals, Inc.'s (NASDAQ:ADRX) Quiet Period To Expire on November 4th

Published by MarketBeat · United States 1 h ago

ADARx Pharmaceuticals' (NASDAQ:ADRX - Get Free Report) quiet period is set to end on Wednesday, November 4th. ADARx Pharmaceuticals had issued 26,250,000 shares in its public…

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

Seeking Alpha

Dassault Systèmes lifts 2026 revenue growth target to 4%-5% after Q3 results

The Motley Fool

Billionaire Ken Griffin Says AI Is "Almost Certainly" in a Bubble. Here's What That Means for Crypto Investors.

Investing.com

Why is Samsung Electro-Mechanics stock surging today?

MarketWatch

A leading Silicon Valley cheerleader just showed all the reasons to be worried about the AI bubble

TheStreet

Dave Ramsey’s crisp strategy for 401(k)s, Roth IRAs (with the math)

Benzinga